Doxepin

Common brands: Neurontin, Gralise, Gaba 300-Ezs, Gabapentin, Gabarone

Top reporter: Actavis Pharma, Inc.

Benzodiazepine [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Atypical Antipsychotic [EPC]Proton Pump Inhibitor [EPC]
9,955
Total Reports
4,189
Serious Reports
1,790
Death Reports
30
Reported Reactions
Death Report Ratio: High (17.98%)

Patient Demographics

Male
2,890
Female
6,222

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Doxepin.

# Reaction Reports % of Total
1 TOXICITY TO VARIOUS AGENTS 825
6.6%
2 DRUG INEFFECTIVE 727
5.8%
3 COMPLETED SUICIDE 635
5.1%
4 FATIGUE 605
4.8%
5 NAUSEA 564
4.5%
6 PAIN 532
4.2%
7 HEADACHE 485
3.9%
8 PRURITUS 475
3.8%
9 OFF LABEL USE 473
3.8%
10 DIARRHOEA 439
3.5%
11 DYSPNOEA 425
3.4%
12 INSOMNIA 420
3.3%
13 CHRONIC KIDNEY DISEASE 408
3.3%
14 DIZZINESS 407
3.2%
15 ANXIETY 405
3.2%
16 DEPRESSION 398
3.2%
17 FALL 388
3.1%
18 URTICARIA 368
2.9%
19 DEATH 367
2.9%
20 DRUG INTERACTION 331
2.6%
21 VOMITING 314
2.5%
22 WEIGHT DECREASED 313
2.5%
23 MALAISE 302
2.4%
24 ASTHENIA 295
2.4%
25 ACUTE KIDNEY INJURY 294
2.3%
26 ARTHRALGIA 291
2.3%
27 RASH 271
2.2%
28 RENAL FAILURE 271
2.2%
29 SOMNOLENCE 269
2.1%
30 DRUG ABUSE 256
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.